Yi H[au] - Search Results

Year	Number of Results
1958	1
1979	1
1981	1
1983	1
1984	1
1986	1
1989	2
1991	7
1992	6
1993	9
1994	10
1995	16
1996	10
1997	10
1998	9
1999	9
2000	14
2001	15
2002	25
2003	37
2004	47
2005	62
2006	83
2007	80
2008	97
2009	102
2010	115
2011	149
2012	186
2013	197
2014	216
2015	222
2016	267
2017	256
2018	304
2019	312
2020	327
2021	390
2022	447
2023	98

1

Butyrate-producing Eubacterium rectale suppresses lymphomagenesis by alleviating the TNF-induced TLR4/MyD88/NF-κB axis.

Lu H, Xu X, Fu D, Gu Y, Fan R, Yi H, He X, Wang C, Ouyang B, Zhao P, Wang L, Xu P, Cheng S, Wang Z, Zou D, Han L, Zhao W. Lu H, et al. Among authors: yi h. Cell Host Microbe. 2022 Aug 10;30(8):1139-1150.e7. doi: 10.1016/j.chom.2022.07.003. Cell Host Microbe. 2022. PMID: 35952646

2

PARPi treatment enhances radiotherapy-induced ferroptosis and antitumor immune responses via the cGAS signaling pathway in colorectal cancer.

Shen D, Luo J, Chen L, Ma W, Mao X, Zhang Y, Zheng J, Wang Y, Wan J, Wang S, Ouyang J, Yi H, Liu D, Huang W, Zhang W, Liu Z, McLeod HL, He Y. Shen D, et al. Among authors: yi h. Cancer Lett. 2022 Dec 1;550:215919. doi: 10.1016/j.canlet.2022.215919. Epub 2022 Sep 16. Cancer Lett. 2022. PMID: 36116741

3

Heme oxygenase-1 and hemopexin gene polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity in China.

Liu W, Lu L, Pan H, He X, Zhang M, Wang N, Zhu J, Yi H, Tang S. Liu W, et al. Among authors: yi h. Pharmacogenomics. 2022 May;23(7):431-441. doi: 10.2217/pgs-2022-0015. Epub 2022 Apr 26. Pharmacogenomics. 2022. PMID: 35470713 Free article.

4

Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma.

Zhu Y, Fu D, Shi Q, Shi Z, Dong L, Yi H, Liu Z, Feng Y, Liu Q, Fang H, Cheng S, Wang L, Tian Q, Xu P, Zhao W. Zhu Y, et al. Among authors: yi h. Front Immunol. 2022 Mar 25;13:842439. doi: 10.3389/fimmu.2022.842439. eCollection 2022. Front Immunol. 2022. PMID: 35401516 Free PMC article.

5

The SWI/SNF chromatin remodeling factor DPF3 regulates metastasis of ccRCC by modulating TGF-β signaling.

Cui H, Yi H, Bao H, Tan Y, Tian C, Shi X, Gan D, Zhang B, Liang W, Chen R, Zhu Q, Fang L, Gao X, Huang H, Tian R, Sperling SR, Hu Y, Chen W. Cui H, et al. Among authors: yi h. Nat Commun. 2022 Aug 9;13(1):4680. doi: 10.1038/s41467-022-32472-0. Nat Commun. 2022. PMID: 35945219 Free PMC article.

6

Sclerostin as a Putative Myokine in Sarcopenia.

Yi HS. Yi HS. Endocrinol Metab (Seoul). 2022 Jun;37(3):430-431. doi: 10.3803/EnM.2022.303. Epub 2022 Jun 29. Endocrinol Metab (Seoul). 2022. PMID: 35798549 Free PMC article. No abstract available.

7

Mesenchymal stromal cells alleviate acute respiratory distress syndrome through the cholinergic anti-inflammatory pathway.

Zhang X, Wei X, Deng Y, Yuan X, Shi J, Huang W, Huang J, Chen X, Zheng S, Chen J, Chen K, Xu R, Wang H, Li W, Li S, Yi H, Xiang AP. Zhang X, et al. Among authors: yi h. Signal Transduct Target Ther. 2022 Sep 5;7(1):307. doi: 10.1038/s41392-022-01124-6. Signal Transduct Target Ther. 2022. PMID: 36064538 Free PMC article.

8

Mitoribosomal defects aggravate liver cancer via aberrant glycolytic flux and T cell exhaustion.

Song BS, Moon JS, Tian J, Lee HY, Sim BC, Kim SH, Kang SG, Kim JT, Nga HT, Benfeitas R, Kim Y, Park S, Wolfe RR, Eun HS, Shong M, Lee S, Kim IY, Yi HS. Song BS, et al. Among authors: yi hs. J Immunother Cancer. 2022 May;10(5):e004337. doi: 10.1136/jitc-2021-004337. J Immunother Cancer. 2022. PMID: 35580931 Free PMC article.

9

Lactobacillus rhamnosus GG Derived Extracellular Vesicles Modulate Gut Microbiota and Attenuate Inflammatory in DSS-Induced Colitis Mice.

Tong L, Zhang X, Hao H, Liu Q, Zhou Z, Liang X, Liu T, Gong P, Zhang L, Zhai Z, Hao Y, Yi H. Tong L, et al. Among authors: yi h. Nutrients. 2021 Sep 23;13(10):3319. doi: 10.3390/nu13103319. Nutrients. 2021. PMID: 34684320 Free PMC article.

10

Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma.

Qu LH, Fang Q, Yin T, Yi HM, Mei GB, Hong ZZ, Qiu XB, Zhou R, Dong HF. Qu LH, et al. Among authors: yi hm. Cancer Immunol Immunother. 2022 Oct;71(10):2449-2467. doi: 10.1007/s00262-022-03167-8. Epub 2022 Mar 7. Cancer Immunol Immunother. 2022. PMID: 35254477

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results